🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
The purpose of this study is to assess the efficacy and safety of the combi...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute ( Site 0065)
Start Date
2019-05-02
Trial ID
NCT03834506
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
This phase I/II trial studies the best dose and side effects of mogamulizum...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-10-24
Trial ID
NCT03309878
Treatments Being Tested
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of pembrol...
Status
Completed
Location
St Joseph Heritage Healthcare-Oncology ( Site 0004)
Start Date
2021-10-07
Trial ID
NCT05008224
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-05-01
Trial ID
NCT04863079
Treatments Being Tested
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of divaras...
Status
Recruiting
Location
Alaska Oncology and Hematology
Start Date
2025-10-24
Trial ID
NCT06793215
Treatments Being Tested